ArticleResearch square2026
Detection of Lipid-Mediated Diffused Pathological Changes in Multiple Sclerosis.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Background: Lipid dysregulation and myelin breakdown are hallmark features of multiple sclerosis (MS), yet current noninvasive biomarkers have limited sensitivity for detecting both focal demyelination and diffuse microstructural injury. We evaluated transient nuclear Overhauser effect (tNOE) MRI, a lipid-sensitive imaging technique, for mapping myelin-related alterations in MS. Methods: tNOE-MRI was performed in four MS patients and four healthy controls using a 7T scanner equipped with a 32-channel receive phased-array coil. Scan reproducibility was assessed across repeated sessions, and tNOE signal patterns were analyzed in major white-matter regions, including corpuscallosum and internal-capsule. Results: tNOE maps demonstrated strong contrast in highly myelinated structures, like splenium of corpuscallosum and internal-capsule. Inter-day and intra-day coefficients of variation were < 5%, indicating high measurement consistency. Quantitative analysis revealed that MS patients had significantly lower tNOE contrast in white-matter (12.6%vs16.1%) and grey-matter (5.9%vs7.2%) compared to healthy controls. The splenium exhibited the greatest tNOE reduction (~ 36%) in MS. Discussion: Reduced tNOE contrast corresponded with known regional differences in myelin density and suggests sensitivity to myelin-integrity. Lower tNOE signals in both white and gray matter indicate diffuse tissue alterations beyond focal lesions. With an acquisition time of ~ 3 minutes, tNOE-MRI shows promise as a rapid biomarker for MS diagnosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.